Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
-103.05%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cogent Biosciences, Inc.
Market Cap
$5.27B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.35B
Operating Margin
29.60%
TTM Avg
36.63%
3Y Avg
34.40%
5Y Avg
32.73%
Market Cap
$5.20B
Operating Margin
12.75%
TTM Avg
11.82%
3Y Avg
10.28%
5Y Avg
7.77%
Market Cap
$5.20B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.20%
5Y Avg
-276.55%
Market Cap
$5.53B
Operating Margin
-16191.40%
TTM Avg
-8762.23%
3Y Avg
-42994.83%
5Y Avg
-36872.33%
Market Cap
$5.02B
Operating Margin
10.90%
TTM Avg
-12.82%
3Y Avg
-40.85%
5Y Avg
-40.85%
Market Cap
$4.92B
Operating Margin
-8739.34%
TTM Avg
-5186.54%
3Y Avg
-3135.16%
5Y Avg
-2237.88%
Market Cap
$4.81B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.27B | 0.00% | 0.00% | 0.00% | 0.00% |
| Doximity, Inc. (DOCS)vs › | $5.35B | 29.60% | 36.63% | 34.40% | 32.73% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 12.75% | 11.82% | 10.28% | 7.77% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | 0.00% | 0.00% | -101.20% | -276.55% |
| Erasca, Inc. (ERAS)vs › | $5.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.53B | -16191.40% | -8762.23% | -42994.83% | -36872.33% |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | 10.90% | -12.82% | -40.85% | -40.85% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | -8739.34% | -5186.54% | -3135.16% | -2237.88% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | 0.00% | 0.00% | 0.00% | 0.00% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.78B | -20.62% | -55.73% | -88.20% | -107.26% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | -18333.01% |
| 2020-06-30 | -1402.08% |
| 2020-03-31 | -87.34% |
| 2019-12-31 | 14.65% |
| 2019-09-30 | -1180.00% |
| 2019-06-30 | -335.91% |
| 2019-03-31 | -387.85% |
| 2018-12-31 | -236.64% |
| 2018-09-30 | -517.67% |
| 2018-06-30 | -566.57% |
| 2018-03-31 | -314.68% |
| 2017-12-31 | -324.07% |
| 2017-09-30 | -307.59% |
| 2017-06-30 | -290.19% |
| 2017-03-31 | -332.18% |
| 2016-09-30 | -23.68% |
| 2015-09-30 | -451.40% |
